JPH05507842A - 生ワクチン - Google Patents
生ワクチンInfo
- Publication number
- JPH05507842A JPH05507842A JP91506347A JP50634791A JPH05507842A JP H05507842 A JPH05507842 A JP H05507842A JP 91506347 A JP91506347 A JP 91506347A JP 50634791 A JP50634791 A JP 50634791A JP H05507842 A JPH05507842 A JP H05507842A
- Authority
- JP
- Japan
- Prior art keywords
- attenuated
- microorganism
- dna
- base sequence
- microorganisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (16)
- 1.環境的ストレスに応じて生ずるタンパク質をコードしている微生物のDNA 塩基配列或いはコードしているDNAの発現を調節するDNA塩基配列における 変異の存在によって弱毒性のもたらされた、免疫予防に使用される弱毒化微生物 であって、異種抗原をコードするDNAを任意に発現し得る該微生物。
- 2.タンパク質がヒートショックタンパク質、栄養分損失タンパク質、毒物スト レスタンパク質及び代謝危機タンパク質から選ばれることを特徴とする請求の範 囲第1項記載の弱毒化微生物。
- 3.タンパク質がヒートショックタンパク質であることを特徴とする請求の範囲 第2項記載の弱毒化微生物。
- 4.タンパク質がhtrA遺伝子にコードされていることを特徴とする請求の範 囲第3項記載の弱毒化微生物。
- 5.変異が削除或いは挿入による変異であることを特徴とする請求の範囲第1項 記載の弱毒化微生物。
- 6.微生物が細菌であることを特徴とする請求の範囲第1項記載の弱毒化微生物 。
- 7.細菌がサルモネラ属、ボルデェテラ属、ヴィプリオ属、ヘモフィルス属及び エッシャリヒィア属から選ばれる請求の範囲第6項記載の弱毒化微生物。
- 8.サルモネラ細菌が、チフス菌、ネズミチフス菌、サルモネラエンテリティデ ィス及びサルモネラコレラスイスから選ばれる請求の範囲第7項記載の弱毒化微 生物。
- 9.弱毒化が第2のDNA塩基配列の変異によってももたらされていることを特 徴とする請求の範囲第1項記載の弱毒化微生物。
- 10.2番目のDNA塩基配列の変異が芳香族アミノ酸の生合成経路に関与する DNA塩基配列内にあることを特徴とする請求の範囲第9項の弱弱毒化微生物。
- 11.芳香族アミノ酸の生合成経路に関与するDNA塩基配列がaro C、a roA及びaro Dから選ばれることを特徴とする請求の範囲第10項の弱毒 化微生物。
- 12.異種抗原をコードするDNAを発現し得る請求の範囲第1項記載の弱毒化 微生物。
- 13.請求の範囲第1項〜第12項に請求した弱毒化微生物の有用な量とその為 に薬学的に受容し得るキャリアーとから成るワクチン。
- 14.経口投与用に適合する様にした請求の範囲第13項記載のワクチン。
- 15.微生物によって引き起こされる感染に対する宿主の予防処置方法であって 、請求の範囲第13項記載のワクチンを有効量、前記宿主に投与することを含む 予防処理方法。
- 16.請求の範囲第1項記載の微生物の生産工程であって、 a)トランスポゾン変異又は b)環境的ストレスに応じて生じる非復帰の変異を含むタンパク質をコードする 或いはコードするDNA塩基配列の発現を調節するDNA塩基配列を取り込んだ ベクターを用いて微生物を形質転換するそして c)好ましい微生物を選抜する為にスクリーニングを行う のいずれかによって、環境的ストレスに応じて生ずるタンパク質をコードする或 いはコードするDNAの発現を調節する微生物のDNA塩基配列に変異を導入す ることから成る微生物の生産工程。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909007194A GB9007194D0 (en) | 1990-03-30 | 1990-03-30 | Live vaccines |
GB9007194.5 | 1990-03-30 | ||
PCT/GB1991/000484 WO1991015572A1 (en) | 1990-03-30 | 1991-03-28 | Live vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05507842A true JPH05507842A (ja) | 1993-11-11 |
JP3054440B2 JP3054440B2 (ja) | 2000-06-19 |
Family
ID=10673583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3506347A Expired - Lifetime JP3054440B2 (ja) | 1990-03-30 | 1991-03-28 | 生ワクチン |
Country Status (19)
Country | Link |
---|---|
US (2) | US5804194A (ja) |
EP (1) | EP0524205B1 (ja) |
JP (1) | JP3054440B2 (ja) |
KR (1) | KR100202771B1 (ja) |
AT (1) | ATE157397T1 (ja) |
CA (1) | CA2079463C (ja) |
DE (1) | DE69127440T2 (ja) |
DK (1) | DK0524205T3 (ja) |
ES (1) | ES2106776T3 (ja) |
GB (1) | GB9007194D0 (ja) |
GR (1) | GR3025258T3 (ja) |
HU (1) | HU217776B (ja) |
IE (1) | IE911037A1 (ja) |
IL (1) | IL97720A (ja) |
MY (1) | MY130001A (ja) |
NZ (1) | NZ237616A (ja) |
TW (1) | TW205567B (ja) |
WO (1) | WO1991015572A1 (ja) |
ZA (1) | ZA912397B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500047A (ja) * | 1997-12-30 | 2002-01-08 | セントロ ナシオナル デ インベスチガシオネス シエンテイフイカス | 新規なコレラ菌ワクチン候補と構築方法 |
JP2002507414A (ja) * | 1998-03-25 | 2002-03-12 | ペプチド セラピューティックス リミテッド | ワクチンに使用する弱毒化細菌 |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5662908A (en) * | 1985-07-31 | 1997-09-02 | The Board Of Trustees Of The Leland Stanford Jr. University | Invasive microorganisms |
WO1994029459A1 (en) | 1993-06-04 | 1994-12-22 | Whitehead Institute For Biomedical Research | Stress proteins and uses therefor |
CA2099841C (en) * | 1991-03-05 | 2003-02-25 | Ian G. Charles | Expression of recombinant proteins in attenuated bacteria |
EP0632834A1 (en) * | 1992-03-02 | 1995-01-11 | The Board Of Trustees Of The Leland Stanford Junior University | Microorganisms having attenuated invasiveness |
CA2143299A1 (en) * | 1992-09-04 | 1994-03-17 | Brenda J. Allan | Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
US5750119A (en) * | 1994-01-13 | 1998-05-12 | Mount Sinai School Of Medicine Of The City University Of New York | Immunotherapeutic stress protein-peptide complexes against cancer |
US5997873A (en) * | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
GB9401795D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccines |
US5961979A (en) * | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
US5985270A (en) * | 1995-09-13 | 1999-11-16 | Fordham University | Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
US5796671A (en) | 1996-03-01 | 1998-08-18 | Wahlstrom; Sven E. | Dynamic random access memory |
US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
US5830464A (en) | 1997-02-07 | 1998-11-03 | Fordham University | Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy |
US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
ATE327259T1 (de) | 1997-08-05 | 2006-06-15 | Stressgen Biotechnologies Corp | Immunantwort gegen hpv antigene hervorgerufen von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einem expressionsvektor fähig zur expression dieser proteine |
US5948646A (en) | 1997-12-11 | 1999-09-07 | Fordham University | Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes |
US6905691B1 (en) | 1997-12-11 | 2005-06-14 | Celltech Pharma Europe Limited | Vaccines containing attenuated bacteria |
DE69935781T2 (de) | 1998-02-20 | 2007-12-27 | University Of Miami, Miami | Modifizierter hitzeschockprotein/peptidantigen komplex |
US6413768B1 (en) | 1998-12-02 | 2002-07-02 | University Of Maryland | Expression plasmids |
NZ511449A (en) * | 1998-12-02 | 2004-05-28 | Univ Maryland | Plasmid maintenance system for antigen delivery |
US8076130B2 (en) | 1998-12-02 | 2011-12-13 | University Of Maryland, Baltimore | Plasmid maintenance system for antigen delivery |
US6497880B1 (en) | 1998-12-08 | 2002-12-24 | Stressgen Biotechnologies Corporation | Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus |
FR2787810B1 (fr) * | 1998-12-24 | 2002-10-31 | Inst Nat De La Rech Agronomique Inra | Bacteries a gram positif depourvues d'activite proteasique htra, et leurs utilisations |
US6495347B1 (en) | 1999-07-08 | 2002-12-17 | Stressgen Biotechnologies Corporation | Induction of a Th1-like response in vitro |
ATE438408T1 (de) | 2000-01-14 | 2009-08-15 | Whitehead Biomedical Inst | Induktion zytotoxischer lymphozyten durch hitzeschockprotein-fusionsproteine hängt von der atp-bindungsdomäne in hsp ab und is cd4+ unabhängig |
WO2001091787A1 (en) | 2000-06-02 | 2001-12-06 | University Of Connecticut Health Center | Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
PT1296711E (pt) | 2000-06-26 | 2006-08-31 | Stressgen Biotechnologies Corp | E7 de vph para o tratamento do virus do papiloma humano |
US6872547B1 (en) | 2000-10-11 | 2005-03-29 | Washington University | Functional balanced-lethal host-vector systems |
WO2002062959A2 (en) | 2001-02-05 | 2002-08-15 | Stressgen Biotechnologies Corp. | Hepatitis b virus treatment |
ITRM20010295A1 (it) * | 2001-05-30 | 2002-12-02 | Stresstech S R L | Metodo per ottenere microrganismi patogeni non virulenti attraverso una modificazione dello stato fisico e/o dinamico delle loro membrane bi |
WO2003015712A2 (en) | 2001-08-20 | 2003-02-27 | University Of Connecticut Health Center | Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin |
GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
US7541043B2 (en) * | 2002-01-16 | 2009-06-02 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine for protection against Shigella sonnei disease |
UA100370C2 (uk) | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
CA2717854C (en) | 2008-03-03 | 2019-02-19 | The University Of Miami | Allogeneic cancer cell-based immunotherapy |
JP2011515399A (ja) | 2008-03-20 | 2011-05-19 | ユニバーシティー オブ マイアミ | 熱ショックタンパクgp96ワクチン接種及びそれを用いた方法 |
IL214246B (en) * | 2011-07-21 | 2018-08-30 | Shafferman Avigdor | Vaccines produced from htra-defective Bacillus anthraxis |
CN106794236B (zh) | 2014-04-15 | 2021-09-03 | 格里菲斯大学 | A群链球菌疫苗 |
CN107208099B (zh) | 2015-02-06 | 2022-05-13 | 热生物制品有限公司 | 共表达疫苗和共刺激分子的载体 |
US11666649B2 (en) | 2016-10-11 | 2023-06-06 | University Of Miami | Vectors and vaccine cells for immunity against Zika virus |
CA3058938A1 (en) | 2017-04-04 | 2018-10-11 | Heat Biologics, Inc. | Intratumoral vaccination |
CN115348968A (zh) | 2019-11-25 | 2022-11-15 | 格里菲斯大学 | 针对淋球菌感染的免疫原性蛋白 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4337314A (en) * | 1979-05-23 | 1982-06-29 | Research Corporation | Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype |
US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
GB8314645D0 (en) * | 1983-05-26 | 1983-06-29 | Wellcome Found | Bivalent vaccines |
EP0300035B1 (en) * | 1987-01-30 | 1995-05-10 | The President And Fellows Of Harvard College | Periplasmic protease mutants of escherichia coli |
US4895717A (en) * | 1987-07-10 | 1990-01-23 | The United States Of America As Represented By The Secretary Of Agriculture | Revertant serotype 1 Marek's disease vaccine |
GB8730037D0 (en) * | 1987-12-23 | 1988-02-03 | Wellcome Found | Vaccines |
US5114844A (en) * | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
GB8912330D0 (en) * | 1989-05-30 | 1989-07-12 | Wellcome Found | Live vaccines |
-
1990
- 1990-03-30 GB GB909007194A patent/GB9007194D0/en active Pending
-
1991
- 1991-03-28 WO PCT/GB1991/000484 patent/WO1991015572A1/en active IP Right Grant
- 1991-03-28 KR KR1019920702407A patent/KR100202771B1/ko not_active IP Right Cessation
- 1991-03-28 CA CA002079463A patent/CA2079463C/en not_active Expired - Lifetime
- 1991-03-28 DE DE69127440T patent/DE69127440T2/de not_active Expired - Lifetime
- 1991-03-28 HU HU9203098A patent/HU217776B/hu unknown
- 1991-03-28 AT AT91906493T patent/ATE157397T1/de not_active IP Right Cessation
- 1991-03-28 MY MYPI91000506A patent/MY130001A/en unknown
- 1991-03-28 EP EP91906493A patent/EP0524205B1/en not_active Expired - Lifetime
- 1991-03-28 ES ES91906493T patent/ES2106776T3/es not_active Expired - Lifetime
- 1991-03-28 IL IL9772091A patent/IL97720A/en not_active IP Right Cessation
- 1991-03-28 TW TW080102452A patent/TW205567B/zh active
- 1991-03-28 JP JP3506347A patent/JP3054440B2/ja not_active Expired - Lifetime
- 1991-03-28 ZA ZA912397A patent/ZA912397B/xx unknown
- 1991-03-28 NZ NZ237616A patent/NZ237616A/en unknown
- 1991-03-28 DK DK91906493.1T patent/DK0524205T3/da active
- 1991-03-28 IE IE103791A patent/IE911037A1/en not_active IP Right Cessation
-
1994
- 1994-12-07 US US08/350,741 patent/US5804194A/en not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/463,875 patent/US5980907A/en not_active Expired - Fee Related
-
1997
- 1997-11-05 GR GR970402896T patent/GR3025258T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500047A (ja) * | 1997-12-30 | 2002-01-08 | セントロ ナシオナル デ インベスチガシオネス シエンテイフイカス | 新規なコレラ菌ワクチン候補と構築方法 |
JP2002507414A (ja) * | 1998-03-25 | 2002-03-12 | ペプチド セラピューティックス リミテッド | ワクチンに使用する弱毒化細菌 |
Also Published As
Publication number | Publication date |
---|---|
GB9007194D0 (en) | 1990-05-30 |
IL97720A0 (en) | 1992-06-21 |
DK0524205T3 (da) | 1997-10-27 |
US5980907A (en) | 1999-11-09 |
JP3054440B2 (ja) | 2000-06-19 |
KR100202771B1 (ko) | 1999-06-15 |
ES2106776T3 (es) | 1997-11-16 |
AU659995B2 (en) | 1995-06-08 |
AU7541791A (en) | 1991-10-30 |
MY130001A (en) | 2007-05-31 |
NZ237616A (en) | 1994-03-25 |
TW205567B (ja) | 1993-05-11 |
IE911037A1 (en) | 1991-10-09 |
IL97720A (en) | 1999-06-20 |
DE69127440D1 (de) | 1997-10-02 |
CA2079463A1 (en) | 1991-10-01 |
ZA912397B (en) | 1992-11-25 |
EP0524205B1 (en) | 1997-08-27 |
HU217776B (hu) | 2000-04-28 |
WO1991015572A1 (en) | 1991-10-17 |
CA2079463C (en) | 2002-03-05 |
ATE157397T1 (de) | 1997-09-15 |
GR3025258T3 (en) | 1998-02-27 |
EP0524205A1 (en) | 1993-01-27 |
DE69127440T2 (de) | 1998-01-02 |
HU9203098D0 (en) | 1992-12-28 |
US5804194A (en) | 1998-09-08 |
HUT65496A (en) | 1994-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05507842A (ja) | 生ワクチン | |
EP0315682B1 (en) | Avirulent microbes and uses therefor | |
EP0400958B1 (en) | Live vaccines | |
JP3004049B2 (ja) | 病原性のないphoP型微生物を含有するワクチン | |
US5468485A (en) | Avirulent microbes and uses therefor | |
JPH06505158A (ja) | 弱毒化細菌における組換えタンパク質の発現 | |
US20110287052A1 (en) | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae | |
Cheminay et al. | Rational design of Salmonella recombinant vaccines | |
CA2097931C (en) | Salmonella vaccines | |
EP0322237B1 (en) | Vaccines | |
EP2403525B1 (en) | Attenuated salmonella enterica serovar paratyphi a and uses thereof | |
CA2626114A1 (en) | Attenuated salmonella enterica serovar paratyphi a and uses thereof | |
AU5355990A (en) | Avirulent microbes and uses therefor | |
US5811105A (en) | Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway | |
AU659995C (en) | Live vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090407 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090407 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100407 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110407 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term |